Related Experiment Video

Updated: Jun 30, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells

Aaron G Smith1, Kimberley A Beaumont, Darren J Smit

  • 1The University of Queensland, Institute for Molecular Bioscience, Qld 4072, Australia. a.smith@imb.uq.edu.au

The International Journal of Biochemistry & Cell Biology
|September 30, 2008
PubMed

Insights

Peroxisome proliferator-activated receptor-gamma (PPARgamma) agonists show anti-cancer effects in melanoma. PPARgamma directly mediates these anti-proliferative effects by regulating cell cycle genes and beta-catenin signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Peroxisome proliferator-activated receptor-gamma (PPARgamma), a nuclear hormone receptor, is implicated in cellular regulation.
  • PPARgamma agonists, like thiazolidinediones (TZDs), show potential as anti-cancer agents, particularly in melanoma.
  • The precise mechanisms by which PPARgamma influences melanoma cell proliferation are not fully understood.

Purpose of the Study:

  • To investigate the anti-proliferative effects of PPARgamma modulators in human melanoma cell lines.
  • To elucidate the role of PPARgamma in mediating these anti-proliferative effects.
  • To explore the molecular mechanisms, including cell cycle gene and Wnt/beta-catenin pathway regulation, involved in PPARgamma's action in melanoma.

Main Methods:

  • Utilized full and partial PPARgamma modulators on human melanoma cell lines.
  • Employed siRNA-mediated ablation of PPARgamma expression in MM96L melanoma cells.
  • Analyzed the regulation of critical cell cycle genes and beta-catenin expression.
  • Investigated the modulation of Wnt/beta-catenin signaling pathways.

Main Results:

  • Demonstrated significant anti-proliferative effects of PPARgamma modulators in human melanoma cells.
  • Confirmed that PPARgamma directly mediates the anti-proliferative effects, as evidenced by siRNA-mediated ablation.
  • Identified regulation of key cell cycle genes and beta-catenin as mechanisms underlying PPARgamma's anti-proliferative action.
  • Showed that PPARgamma modulates Wnt/beta-catenin signaling in a manner dependent on agonist presence.

Conclusions:

  • PPARgamma plays a direct role in inhibiting melanoma cell proliferation.
  • The anti-proliferative effects are mediated through the regulation of cell cycle genes and the Wnt/beta-catenin signaling pathway.
  • PPARgamma agonists represent a promising therapeutic strategy for melanoma, warranting further investigation into their mechanisms of action.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...